Sab Biotherapeutics Inc. (SABS) at a glance

Sab Biotherapeutics Inc. (SABS) is a micro-cap Healthcare company. It trades at $3.81, with a P/E of 18.1 and a 0% profit margin. It does not pay a dividend. Vestovix scores it 54/100 overall. Its strongest dimension is Value (68/100) and its weakest is Income (40/100).

Price
$3.81
Market cap
$254.6M
P/E ratio
18.1
Dividend yield
None
Beta
n/a
52-week range
$1.85 to $5.15
Vestovix Score54/ 100How this works
Value
68
Growth
50
Income
40
Safety
52
Momentum
57

Other Healthcare stocks

See all